Revenue Recognition (Tables)

3 Months Ended

Mar. 31, 2026

Revenue from Contract with Customer [Abstract]

Schedule of Revenue by Payer Type

The following table shows disaggregation of revenues by payer types:

	Three months ended March 31,
	2026		2025
	(in thousands)
Insurance carriers	$	658,089	$	472,647
Laboratory partners	28,817		20,832
Patients	9,738		8,351
Total revenues	$	696,644	$	501,830

Schedule of Total Revenue by Geographic Area

The following table presents total revenues by geographic area based on the location of the Company’s payers:

	Three months ended March 31,
	2026		2025
	(in thousands)
United States	$	685,598	$	492,305
Americas, excluding U.S.	2,402		1,692
Europe, Middle East, India, Africa	6,425		6,049
Asia Pacific and Other	2,219		1,784
Total revenues	$	696,644	$	501,830

Schedule of Changes in the Balance of Deferred Revenues

The following table summarizes the changes in the balance of deferred revenues during the three months ended March 31, 2026 and 2025:

	Balance at March 31,
	2026		2025
	(in thousands)
Beginning balance	$	41,969	$	36,592
Increase in deferred revenues	28,431		10,163
Revenue recognized during the period included in deferred revenues at the beginning of the period	(11,305)		(9,418)
Revenue recognized from performance obligations satisfied within the same period	(5,234)		(75)
Ending balance	$	53,861	$	37,262